Page results
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.
-
Penile plication (Nesbit) procedure post-operative information
-
Information on the insertion of an inflatable penile prosthesis
-
Patient Advice and Liaison Service (PALS)
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Information about the Integrated Women's Service at the RLHIM patient information leaflet
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
File results
-
FOI/2023/0224 - Patients prescribed medical equipment for use in the home
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0218 - System for discharge letters, diagnostic reporting, digital dictation & bed management
-
FOI/2023/0217 - Integration platform(s) at the Trust
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times
-
FOI/2023/0115 - Deaths in A&E
-
FOI/2023/0114 - Electronic Patient Record/ Electronic Health Record systems
-
FOI/2023/0111 - Migraine treatment
-
FOI/2023/0117 - EPRR Team contact information